GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (BSP:W2ST34) » Definitions » Issuance of Debt

West Pharmaceutical Services (BSP:W2ST34) Issuance of Debt : R$0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is West Pharmaceutical Services Issuance of Debt?

West Pharmaceutical Services's Issuance of Debt for the three months ended in Mar. 2024 was R$0 Mil.

West Pharmaceutical Services's Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2024 was R$0 Mil.


West Pharmaceutical Services Issuance of Debt Historical Data

The historical data trend for West Pharmaceutical Services's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services Issuance of Debt Chart

West Pharmaceutical Services Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 814.74 - - - -

West Pharmaceutical Services Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

West Pharmaceutical Services Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


West Pharmaceutical Services Issuance of Debt Related Terms

Thank you for viewing the detailed overview of West Pharmaceutical Services's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


West Pharmaceutical Services (BSP:W2ST34) Business Description

Traded in Other Exchanges
Address
530 Herman O. West Drive, Exton, PA, USA, 19341-0645
West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.

West Pharmaceutical Services (BSP:W2ST34) Headlines

No Headlines